Aesler Grup Internasional Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Aesler Grup Internasional Tbk. trades at Rp1,390 (market cap 1.81T, 8.8K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Aesler Grup Internasional Tbk. is far larger — about 17.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| RONY | SCPI | |
|---|---|---|
Market Cap | 1.81T | 104.4B |
Volume | 8.8K | — |
Lot | 88 | — |
Turnover | 12.13M | — |
Average Price | 1,378.47 | — |
Value | 12.13M | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Aesler Grup Internasional Tbk (the Company) was established in Republic of Indonesia based on the Notarial Deed No. 14 dated August 4, 2017 of Ferdinandus Indra Santoso Atmajaya, S.H., M.Kn., Notary in Jakarta. The Company started its commercial activity in 2017.
Read more on RONY →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →